Skip to main content

Exodus Movement, Inc. April 2026 Treasury Update and Monthly Metrics

OMAHA, Neb., May 20, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus” or “the company”), a leading self-custodial finance and cryptocurrency platform, today announced updated digital asset holdings, user metrics, and exchange provider processed volume metrics, as of April 30, 2026. “We’re building a business where the topline holds up when consumer trading softens, and the partner channel is part of that work,” said James Gernetzke, CFO at Exodus. “XO Swap volume grew 44% month-over-month in April to $98 million and now represents 28% of total swap volume, up from 20% in March — the highest partner mix share since November.” “We spent a decade building a place where consumers could hold their assets. Now we’ve built a place where they can spend...

Continue reading

Sysco to Webcast Presentation at the Deutsche Bank Access Global Consumer Conference 2026

HOUSTON, May 20, 2026 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) today announced that the Company will webcast its presentation from the 2026 Deutsche Bank Access Global Consumer Conference in Paris, France on Tuesday, June 2, at 8:45 a.m. CT or 3:45 p.m. CEST. The live webcast for the event can be accessed at investors.sysco.com. An archived replay of the webcast will be available shortly after the live event is completed. For purposes of public disclosure, including this and future similar events, Sysco uses the investor relations portion of its website as the primary channel for publishing key information to its investors, some of which may contain material and previously non-public information. About Sysco Sysco is the global leader in selling, marketing and distributing food and related products to customers who prepare...

Continue reading

LeMaitre to Participate at Upcoming Investor Conferences in June

BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June. Jefferies Global Healthcare Conference Wednesday, June 3, 2026Marriott Marquis, New York CityManagement will participate in a fireside chat at 10:30 AM EDT Goldman Sachs Annual Global Healthcare ConferenceWednesday, June 10, 2026Loews Miami Beach Hotel, Miami BeachManagement will present at 9:20 AM EDT About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional...

Continue reading

NVIDIA Announces Financial Results for First Quarter Fiscal 2027

NVIDIA corporate headquartersNVIDIA corporate headquarters in Silicon ValleyRecord revenue of $81.6 billion, up 85% from a year ago Record Data Center revenue of $75.2 billion, up 92% from a year ago NVIDIA announces $80.0 billion additional share repurchase authorization and increases its quarterly cash dividend from $0.01 per share to $0.25 per shareSANTA CLARA, Calif., May 20, 2026 (GLOBE NEWSWIRE) — NVIDIA (NASDAQ: NVDA) today reported record revenue for the first quarter ended April 26, 2026, of $81.6 billion, up 20% from the previous quarter and up 85% from a year ago. For the quarter, GAAP and non-GAAP gross margins were 74.9% and 75.0%, respectively. For the quarter, GAAP and non-GAAP earnings per diluted share were $2.39 and $1.87, respectively. “The buildout of AI factories — the largest infrastructure expansion...

Continue reading

Gaming and Leisure Properties Increases Quarterly Cash Dividend by 5% and Declares Second Quarter 2026 Cash Dividend of $0.82 Per Share

WYOMISSING, Pa., May 20, 2026 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) (“GLPI” or the “Company”), announced today that the Company’s Board of Directors has declared the second quarter 2026 cash dividend of $0.82 per share of its common stock, marking an increase of $.04 per share per quarter from the prior level. The dividend is payable on June 26, 2026 to shareholders of record on June 12, 2026. Based on GLPI’s closing share price of $47.22 on May 20, the current dividend, on an annualized basis, reflects a yield of 6.95%. The second quarter 2025 cash dividend was $0.78 per share of the Company’s common stock. While the Company intends to pay regular quarterly cash dividends for the foreseeable future, all subsequent dividends will be reviewed quarterly and declared by the Board of Directors at its...

Continue reading

OMNIQ Reports First Quarter 2026 Financial Results

OMNIQ Reports 7.7 Million in First Quarter Revenues SALT LAKE CITY, May 20, 2026 (GLOBE NEWSWIRE) — OMNIQ Corp (OTCMTS: OMQS or “OMNIQ” or “the Company”) today announced its financial results for the first quarter 2026. The Company reported $7.7 million in quarterly revenue as well as a gross profit increase of 3.3 percent year over year. The Company continues to implement its product focus and cost-reduction strategy designed to increase revenue & footprint, strengthen profitability, and support long-term operational efficiency. Financial Highlights For the three months ended March 31, 2026, compared to the same period in 2025:Revenue was $7.68 million, compared to $7.98 million in the prior-year period. Gross profit increased to $2.255 million, compared to $2.184 million last year. Loss from operations was ($1.2 million),...

Continue reading

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

Year-over-year revenue increased 70%, reflecting contribution from Vivos’ acquisition of The Sleep Center of Nevada Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May 20, 2026 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associated chronic health conditions, including obstructive sleep apnea (“OSA”), today reported financial results and operating highlights for the first quarter ended March 31, 2026. Kirk Huntsman, Vivos’ Chairman and Chief Executive Officer, stated “Our significant revenue increase year over year and quarter over quarter confirms what we emphatically stated when we reported our 2025 year end results last month: that the fourth...

Continue reading

StepStone Group Reports Fourth Quarter and Fiscal Year 2026 Results

NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) — StepStone Group Inc. (Nasdaq: STEP), a global private markets investment firm focused on providing customized investment solutions and advisory and data services, today reported results for the quarter ended March 31, 2026. This represents results for the fourth quarter and fiscal year ended March 31, 2026. The Board of Directors of the Company has declared a quarterly cash dividend of $0.28 per share of Class A common stock, and a supplemental cash dividend of $0.55 per share of Class A common stock, both payable on June 30, 2026, to the holders of record as of the close of business on June 15, 2026. StepStone issued a full detailed presentation of its fourth quarter and full fiscal year ended March 31, 2026 results, which can be accessed by visiting the Company’s website at https://shareholders.stepstonegroup.com. Webcast...

Continue reading

American Fusion Inc. (OTC: AMFN) Reports First Quarter 2026 Financial Results, Outlines Reverse Recapitalization Accounting Treatment, and Provides Operational Update

SOUTHLAKE, Texas, May 20, 2026 (GLOBE NEWSWIRE) — American Fusion Inc. (OTC: AMFN) (“American Fusion” or the “Company”), a company developing advanced fusion energy technologies, including its Texatron™ Fusion Engine™ platform, today filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 with the U.S. Securities and Exchange Commission. This filing represents the Company’s first quarterly report reflecting the consolidated operations of American Fusion and Kepler Fusion Technologies following the closing of the previously announced reverse-merger share exchange on February 27, 2026. First Quarter 2026 Financial Highlights Selected financial information for the three months ended March 31, 2026, compared to the corresponding period in 2025 and balances at December 31, 2025 (audited), is summarized...

Continue reading

AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement

OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”, today announced that it has entered into definitive agreements for a registered direct offering priced at-the-market under NYSE Rules of an aggregate of 7,519,351 shares of common stock, par value $0.001 per share (the “Common Stock”) (or common stock equivalents in lieu thereof) at a purchase price of $0.325 per share. The gross proceeds to the Company from the offering are expected to be approximately $2.4 million, before deducting placement agent commissions and other offering expenses. In addition, in a concurrent private placement, the Company will issue and sell unregistered Series I warrants (the “Series I Warrants”) to purchase up to 15,038,702 shares of Common Stock. The Series I Warrants will have an exercise...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.